Expression of a transforming Harvey or Kirsten ras gene caused opposing effects in the ability of plateletderived growth factor (PDGF) and bradykinin to activate phospholipase C-mediated phosphoinositide hydrolysis. In [3H]inositol-labeled rat-l fibroblasts, PDGF (5 ng/ml) resulted in a 2-fold increase in the level of [3H] accumulation. In contrast to this ras-induced desensitization to PDGF, ras-transformed NIH 3T3 cells exhibited an enhanced sensitivity to bradykinin; this effect was associated with an elevated level of high-affinity [3H]bradykinin binding. We propose that a ras gene product (p21) can, directly or indirectly, influence growth factor-stimulated phosphoinositide hydrolysis, as well as DNA synthesis, via alterations in the properties of specific growth factor receptors.
Similarly, marked stimulations by PDGF were observed in NIH 3T3 cells, as well as in v-src-transformed 3T3 cells, but not in 3T3 cells transformed by Kirsten sarcoma virus or by transfection with v-Ha-ras DNA. This diminished phosphoinositide response in ras-transformed cells was associated with a markedly attenuated mitogenic response to PDGF. On the other hand, both phosphoinositide metabolism and DNA synthesis in ras-transformed fibroblasts were stimulated several-fold by serum. In NIH 3T3 cells carrying a glucocorticoid-inducible v-Ha-ras gene, a close correlation was found between the expression of p2lraS and the loss of PDGF-stimulated [3H]InsP1 accumulation. In contrast to this ras-induced desensitization to PDGF, ras-transformed NIH 3T3 cells exhibited an enhanced sensitivity to bradykinin; this effect was associated with an elevated level of high-affinity [3H]bradykinin binding. We propose that a ras gene product (p21) can, directly or indirectly, influence growth factor-stimulated phosphoinositide hydrolysis, as well as DNA synthesis, via alterations in the properties of specific growth factor receptors.
The family of mammalian H-, K-, and N-ras genes encode highly conserved 21-kDa proteins (p2lras) (1, 2) that appear to be intimately involved in the control of cellular growth and differentiation (3) (4) (5) . Certain mutated ras genes, including the v-ras genes of the Harvey and Kirsten murine sarcoma viruses (1) as well as various "activated" ras genes found in many human tumor cells (2, (6) (7) (8) , code for altered p21 proteins capable of transforming morphologically normal cells into tumorigenic cells.
The cellular targets of normal or transforming ras proteins are not known. Normal p21ras proteins associate with the cytoplasmic surface of the plasma membrane (9, 10) , bind guanine nucleotides (11, 12) , and catalyze the hydrolysis of GTP (13) . These observations, together with the homologies between ras proteins and the a-subunits of certain guanine nucleotide regulatory proteins (G-proteins) (14) , have led to the suggestion that p2lras might participate in a G-protein-like manner in some guanine nucleotide-dependent signal-transducing mechanism. In Saccharomyces cerevisiae, ras proteins are required for GTP-stimulated adenylate cyclase activity (15) , although the mechanism of this interaction is not yet clear. The S. cerevisiae cyclase can also be activated by mammalian p2lras (16) , but a similar role for ras proteins in mammalian cells (16, 17) or even in other yeasts (18) has not been demonstrated. Additional clues to possible targets ofthe ras gene product in mammalian cells have been obtained through analysis of ras-induced metabolic alterations. Decreased levels of cAMP (19) , elevated secretion of type a transforming growth factor (20) , enhanced rates of glycolysis and system A amino acid transport (21) , as well as increased activities of phospholipases A2 (22) and C (23, 24) have been observed. Alterations by ras of phospholipase A2 and C activities are ofparticular interest because in some cells these enzymes are influenced by guanine nucleotides (25) (26) (27) (28) . Due to the fact that many or all of these metabolic events are regulated by serum growth factors, however, it is essential to differentiate between an effect of p21ras on the metabolic pathway itself and on the responses of cells to growth factors.
In this paper, we report that expression of a ras oncogene gives rise to marked alterations in the ability of plateletderived growth factor (PDGF) and bradykinin to activate phospholipase C-mediated phosphoinositide hydrolysis. These (31) .
RESULTS AND DISCUSSION Inhibitory Effect of a ras Oncogene on PDGF-Stimulated Phosphoinositide Hydrolysis. As has been shown previously for quiescent Swiss 3T3 cells (39, 40) , confluent cultures of rat-1 and NIH 3T3 cells respond to PDGF with a marked activation of phosphoinositide-specific phospholipase C. However, ras-transformed counterparts of these cells, which exhibit normal levels of cell-surface PDGF receptors (see below), have become refractory to this growth factor. As shown in Table 1 tions, respectively). The cell monolayers were rinsed with serumfree DMEM and then, for InsP3 measurements, incubated for 2 min in 0.7 ml of DMEM either with or without partially purified human platelet PDGF (fraction CMS-III, ref. 31; equivalent to 5 ng/ml of pure PDGF). For InsPj measurements, labeled cells were incubated for 10 min in 1 ml of DMEM containing 25 mM LiCl, and then for an additional 30 min either with or without PDGF [A, purified human platelet PDGF at 10 ng/ml; B, partially purified human platelet PDGF (equivalent to 5 ng/ml of pure PDGF) for Ki-MuSV cells or purified porcine PDGF at 40 ng/ml for v-Ha-ras]. Data represent the means ± SD of triplicate determinations. ND, not determined. *Stereoisomer composition not characterized.
purified human PDGF was dose-dependent, with half-maximal activation at 6 ng/ml (0.2 nM) and with maximal activation at -25 ng/ml (0.8 nM) (Fig. 1) . In EJ-rastransformed cells, there was no significant increase in [3H]-InsPj formation even with levels of PDGF that were saturating for rat-1 cells (up to 92 ng/ml; 3 nM).
Receptor binding experiments with [1251]PDGF were done to determine whether the lack of PDGF response in rastransformed cells might be due to an absence of cell-surface receptors. In parental and EJ-ras-transformed rat-1 cells, equilibrium binding of [1251] PDGF showed that the level of specific binding (up to 3 ng/ml; 96 pM) in EJ-ras cells was -80-90% of that in the parental cells (Fig. 1 Inset) . In parental and v-Ha-ras-transformed NIH 3T3 cells (clone 568), the levels of specific [1251] PDGF binding (at 2 ng/ml) were 28.5 ± 1.0 and 26.8 ± 0.4 fmol/mg of protein (n = 2), respectively. The results suggest that the lack of PDGF response is not due to an absence of cell-surface receptors but is due to some defect distal to PDGF binding.
A diminished response of ras-transformed rat-1 or NIH 3T3 cells to PDGF was also evident when phosphoinositide metabolism was measured as an incorporation of [3H]inositol into total lipids. In other experiments utilizing this assay, we observed that NIH 3T3 cells transfected with the normal rat c-Ha-ras gene (42) , promoted by the Harvey sarcoma virus LTR, exhibit a 40% loss of PDGF-stimulated phosphoinositide metabolism as compared with that in control cells, implying that overexpression of a normal c-ras gene is sufficient to render cells at least partially refractory to PDGF ( ng/ml pure PDGF). Cells were rinsed twice with 1 ml of Dulbecco's phosphate-buffered saline, scraped from the plates in 0.8 ml of 10 mM EDTA/2 mM EGTA (pH 7), and then extracted by vortexing first with 3 ml of chloroform/methanol/12 M HCl (1:2:0.01, vol) and then after the addition of 1 ml of 2.4 M HCl and 1 ml of chloroform. After a brief centrifugation to separate the phases, the chloroform layer and interfacial material were washed three times with 4 ml of 0.1 M HCl, dried, and quantitated for 3H radioactivity. Values are the means ± range of duplicate determinations. DNA synthesis in response to purified porcine PDGF (40 ng/ml) or 10% fetal bovine serum was determined as described. Basal levels of [3H]dThd incorporation (as cpm x 10-3 per 35 mm) were 23.3 ± 1.9 and 296 ± 8 for parental and EJ-ras-transformed rat-i cells, respectively, and 33.7 ± 1.2 and 40.8 ± 7.5 for parental and v-Ha-ras-transformed NIH 3T3 cells, respectively (n = 3, ± SD). (Fig. 3A Inset) . In control NIH 3T3 cells (Fig. 3B) (Fig. 3B Inset) . This effect of dexamethasone on p2iras in control 3T3 cells may be due to an enhanced expression of an endogenous mouse cellular c-ras gene(s), and is consistent with the earlier observation regarding the expression of an LTR-linked c-Ha-ras gene ( Table 2 ) that overproduction of a normal cellular ras protein can be associated with a partial loss ofPDGF response. While these data do not establish a cause and effect relationship between p2lras expression and the loss of PDGF-stimulated phosphoinositide metabolism, they are nevertheless consistent with the hypothesis that p2lras may, directly or indirectly, cause an uncoupling of PDGF receptors from the activation of phosphoinositide-specific phospholipase C.
In other experiments, we have observed that the stimulation of PDGF receptor autophosphorylation is markedly reduced in membranes isolated from ras-transformed cells, as compared with those from control cells. If the PDGF activation of phospholipase C is dependent on the protein tyrosine kinase activity of the PDGF receptor, then a defect in receptor autophosphorylation could account for the lack of PDGF stimulation.
Opposing Effects of ras-Transformation on Phosphoinositide Metabolism Coupled to Receptors for Bradykinin and PDGF. To ascertain whether ras might alter the activation of phosphoinositide-specific phospholipase C via receptors other than for PDGF, we surveyed a variety of factors for differential activation of phosphoinositide metabolism in normal and ras-transformed cells. Although PDGF was the only factor whose response was found to be diminished in the transformed cells, ras-transformed NIH 3T3 cells exhibited a marked increase in sensitivity to bradykinin, a nonapeptide hormone that has previously been shown to induce inositolphospholipid turnover in neuroblastoma-glioma cells (43, 44) and aortic endothelial cells (45) . As shown in Fig. 4 Table 1 .
Dexamethasone (30 nM) was added at times during the labeling period to achieve the indicated time of exposure at the end of the 42 hr. Cells were then treated with LiCl, with or without purified porcine platelet PDGF (40 (Fig. 4B Inset) . Ki-MuSV-transformed 3T3 cells also showed a slightly increased sensitivity to bombesin (1 AM), thrombin (250 ng/ml), prostaglandin F2<1 (10 AtM), and insulin-like growth factor 1 (50 ng/ml). releasing peptide (without any apparent changes in receptor number or affinity), as well as to bradykinin (47) . Conclusions. We have shown here that a ras oncogene can induce marked alterations in the normal patterns of growth factor-stimulated phosphoinositide metabolism. The molecular mechanisms underlying the altered responses are not clear, but the data suggest either a direct or indirect influence of p21ras on the properties of the relevant growth factor receptors. Modifications in growth factor responses may represent a contributing factor in various serum-dependent metabolic abnormalities that have been observed and may also be relevant to the generation of aberrant regulatory signals thought to be involved in transformation.
Finally, we propose that each oncogene can induce a characteristically altered profile ofreceptors that, in turn, influences the pattern of cell metabolism. Both qualitative and quantitative differences in receptor-profiles, as expressed in their responses to growth factors and hormones, should contribute to a picture ofcell individuality that may provide us with a rational approach to the understanding and treatment of the tumor.
